THE PREFERENTIAL CYTOLYTIC T LYMPHOCYTE RESPONSE TO IMMUNODOMINANT MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDES1
- 27 July 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 62 (2) , 283-291
- https://doi.org/10.1097/00007890-199607270-00022
Abstract
C57BL/6 mice preferentially generate cytolytic T lymphocytes (CTL) to a limited number of immunodominant minor antigens and associated immunogenic peptides when primed with H2-matched Balb.B spleen cells despite multiple minor histocompatibility (H) antigen differences. We have examined the complexity of dominant H antigens recognized by these CTLs to estimate the number of peptides associated with single antigens. Peptides eluted from Kb molecules of lymphoblasts from Balb.B and CXB recombinant inbred (RI) strains were tested for sensitization of RMA-S cells for lysis by short-term C57BL/6 CTL lines specific for Balb.B and CXB strains. Anti-Balb.B CTLs recognized four Kb-bound peptides; subsets of these peptides were recognized by anti-CXB CTLs when tested with peptides from the respective CXB strains. Single peptides segregated independently among the CXB strains, confirming that single peptides were encoded by independently segregating alleles. These peptides were expressed in diverse inbred mouse strains and were recognized preferentially by C57BL/6 CTLs stimulated by different inbred mouse strains. This set of peptides was subclassified by their capacity to sensitize targets when presented in unfractionated mixtures of Kb-bound peptides. The peptide associated with the previously classified dominant CTT-2 antigen was the only peptide to strongly sensitize RMA-S cells for lysis under these conditions. These results suggest that dominant peptides have a wide strain distribution and may have a distinct advantage over dominated peptides in binding to class I molecules and/or in presentation to CTLs.Keywords
This publication has 25 references indexed in Scilit:
- Identification of a Graft Versus Host Disease-Associated Human Minor Histocompatibility AntigenScience, 1995
- Dominant and cryptic antigens in the MHC class I restricted T cell response across a complex minor histocompatibility barrier: analysis and mapping by elution of cellular peptidesInternational Immunology, 1995
- Sensitivity enhancement and second-dimensional information from solid phase extraction-capillary electrophoresis of entire high-performance liquid chromatography fractionsElectrophoresis, 1995
- T LYMPHOCYTE RESPONSES TO MULTIPLE MINOR HISTOCOMPATIBILITY ANTIGENS GENERATE BOTH SELF-MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED AND CROSS-REACTIVE CYTOTOXIC T LYMPHOCYTES1Transplantation, 1994
- Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor AntigensScience, 1994
- Few peptides dominate cytotoxic T lymphocyte responses to single and multiple minor histocompatibility antigensInternational Immunology, 1993
- Isolation of an HLA‐A2.1 extracted human minor histocompatibility peptideEuropean Journal of Immunology, 1993
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cellsNature, 1990
- Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.The Journal of Experimental Medicine, 1985